Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
GARDNER JASON
See Remarks at Dianthus Therapeutics, Inc. /DE/. Filing since 25 Jun 2018.
CIK 0001741286
Company
Date
Role
Action
Shares
Amount
Of holding
DNTH
Dianthus Therapeutics, Inc. /DE/
16 Sep 2021
See Remarks
Sold, plan not stated
14,340
$96.51K
4.8%
DNTH
Dianthus Therapeutics, Inc. /DE/
10 Jan 2020
See Remarks
Sold, plan not stated
11,200
$170.80K
4.3%
DNTH
Dianthus Therapeutics, Inc. /DE/
2 Jan 2020
See Remarks
Sold, plan not stated
2,800
$42.28K
1.1%
DNTH
Dianthus Therapeutics, Inc. /DE/
23 Dec 2019
See Remarks
Sold, plan not stated
2,897
$43.75K
1.1%
DNTH
Dianthus Therapeutics, Inc. /DE/
20 Dec 2019
See Remarks
Sold, plan not stated
76,711
$1.16M
22.2%
DNTH
Dianthus Therapeutics, Inc. /DE/
10 Dec 2019
See Remarks
Sold, plan not stated
4,392
$66.32K
1.3%
DNTH
Dianthus Therapeutics, Inc. /DE/
21 Jun 2019
See Remarks
Sold, plan not stated
12,331
$186.32K
3.4%
DNTH
Dianthus Therapeutics, Inc. /DE/
20 Jun 2019
See Remarks
Sold, plan not stated
1,669
$25.20K
0.5%
DNTH
Dianthus Therapeutics, Inc. /DE/
25 Jun 2018
See Remarks
Bought
400
$6.00K
0.1%
9 decisions on file.
